Recombinant human TNF alpha protein
- Bioactive
- What is this?
Be the first to review this product! Submit a review
|
(35 Publications)
Recombinant human TNF alpha protein is a Human Full Length protein, in the 77 to 233 aa range with >98% purity, < 1 EU/µg endotoxin level and suitable for ELISA, SDS-PAGE, Functional studies and HPLC. The predicted molecular weight of ab9642 protein is 17.4 kDa.
- Save time and ensure accurate results - use our TNF alpha protein as a control
- Optimal protein bioactivity and stability
- Available in different sizes to fit your experimental needs
- Cited in over 25 publications
View Alternative Names
TNFA, TNFSF2, TNF, Tumor necrosis factor, Cachectin, TNF-alpha, Tumor necrosis factor ligand superfamily member 2, TNF-a
- sELISA
Supplier Data
Sandwich ELISA - Recombinant human TNF alpha protein (AB9642)
Standard curve for TNF alpha (Analyte : ab9642); dilution range 1pg/ml to 1μg/ml using Capture Antibody Mouse monoclonal [2C8] to TNF alpha (ab8348) at 5μg/ml and Detector Antibody Rabbit polyclonal to TNF alpha (ab9635) at 0.5μg/ml.
- ChIP
Supplier Data
ChIP - Recombinant human TNF alpha protein (AB9642)
Chromatin was prepared from HeLa (human epithelial cell line from cervix adenocarcinoma) cells treated with and without 20 ng/ml TNF-α (ab9642) for 60 minutes according to the Abcam X-ChIP protocol. Cells were fixed with formaldehyde for 10 minutes. The ChIP was performed with 25 μg of chromatin, 5 μg of ab218533 (red), and 20 μl of Protein A/G sepharose beads. 5 μg of rabbit normal IgG was added to the beads control (gray). The immunoprecipitated DNA was quantified by real time PCR (SYBR green approach).
The ChIP data are consistent with the literature (PMID : 16135789).
- IP
Lab
Immunoprecipitation - Recombinant human TNF alpha protein (AB9642)
MLKL (phospho S345) was immunoprecipitated from 1mg of L-929 (Mouse connective tissue fibroblast cells) whole cell lysate treated with 20 ng/ml TNF alpha (ab9642) + 100 nM Smac mimetic + 20 μM z-VAD compound (ab120382) for 8h using ab196436 at 1/150 dilution. Western blot was performed from the immunoprecipitate using ab196436 at 1/1000 dilution. Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG, was used as secondary antibody at 1/1500 dilution.
Lane 1 : L-929 whole cell lysate treated with 20 ng/ml TNF alpha (ab9642) + 100 nM Smac mimetic+ 20 μM z-VAD compound (ab120382) for 8h;10 μg (Input).
Lane 2 : ab196436 IP in L-929 whole cell lysate treated with 20 ng/ml TNF alpha (ab9642) + 100 nM Smac mimetic+ 20 μM z-VAD compound (ab120382) for 8h.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab196436 in L-929 whole cell lysate treated with 20 ng/ml TNF alpha (ab9642) + 100 nM Smac mimetic+ 20 μM z-VAD compound (ab120382) for 8h.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-MLKL (phospho S345) antibody [EPR9515(2)] (<a href='/en-us/products/primary-antibodies/mlkl-phospho-s345-antibody-epr95152-ab196436'>ab196436</a>)
All lanes:
Immunoprecipitation - Recombinant human TNF alpha protein (ab9642)
Predicted band size: 54 kDa
Observed band size: 54 kDa
false
Reactivity data
Have you thought about this alternative?
Recombinant human TNF alpha protein (Active)
Why is this recommended?
We’re constantly upgrading our range to offer the highest quality products. We have selected this alternative product for your review because it gives improved performance, is easier and more convenient to use, or is available faster.
Product details
Analyze your ELISA data using the rTNF alpha ab9642 protein to generate and plot the standard curve.
Check out our protein gel staining guide for SDS-PAGE here
Check out our ELISA protocol for more information here.
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Specifications
Form
Lyophilized
Additional notes
>98% by HPLC analyses.Sterile filtered.
General info
Function
The TNF protein, primarily secreted by macrophages, binds to TNFRSF1A/TNFR1 and TNFRSF1B/TNFBR. It induces cell death in specific tumor cell lines and acts as a potent pyrogen, causing fever directly or by stimulating interleukin-1 secretion. TNF is implicated in cachexia induction and can stimulate cell proliferation and differentiation under certain conditions. It impairs regulatory T-cells (Treg) function in rheumatoid arthritis patients through FOXP3 dephosphorylation, upregulating protein phosphatase 1 (PP1), which dephosphorylates 'Ser-418' of FOXP3, inactivating FOXP3 and leading to defective Treg cells. TNF is a key mediator of cell death in the anticancer effect of BCG-stimulated neutrophils with DIABLO/SMAC mimetic in the RT4v6 bladder cancer cell line. It induces insulin resistance in adipocytes by inhibiting insulin-induced IRS1 tyrosine phosphorylation and glucose uptake. TNF plays a role in angiogenesis by inducing VEGF production with IL1B and IL6. Additionally, the TNF intracellular domain (ICD) form stimulates IL12 production in dendritic cells. This supplementary information is collated from multiple sources and compiled automatically.
Sequence similarities
Belongs to the tumor necrosis factor family.
Post-translational modifications
The soluble form derives from the membrane form by proteolytic processing. The membrane-bound form is further proteolytically processed by SPPL2A or SPPL2B through regulated intramembrane proteolysis producing TNF intracellular domains (ICD1 and ICD2) released in the cytosol and TNF C-domain 1 and C-domain 2 secreted into the extracellular space.. The membrane form, but not the soluble form, is phosphorylated on serine residues. Dephosphorylation of the membrane form occurs by binding to soluble TNFRSF1A/TNFR1.. O-glycosylated; glycans contain galactose, N-acetylgalactosamine and N-acetylneuraminic acid.. Tumor necrosis factor, soluble form. The soluble form is demyristoylated at Lys-19 and Lys-20 by SIRT6, promoting its secretion.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (35)
Recent publications for all applications. Explore the full list and refine your search
Scientific reports 15:21877 PubMed40593292
2025
Applications
Unspecified application
Species
Unspecified reactive species
Acta biochimica et biophysica Sinica : PubMed40437958
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in physiology 16:1547940 PubMed40241717
2025
Applications
Unspecified application
Species
Unspecified reactive species
iScience 28:112105 PubMed40224012
2025
Applications
Unspecified application
Species
Unspecified reactive species
EMBO reports 25:4337-4357 PubMed39242776
2024
Applications
Unspecified application
Species
Unspecified reactive species
Communications biology 7:991 PubMed39143151
2024
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 15:1397432 PubMed38751427
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of biomedical science 31:10 PubMed38243273
2024
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of clinical investigation 134: PubMed37883181
2024
Applications
Unspecified application
Species
Unspecified reactive species
Microbiology spectrum 12:e0275823 PubMed38100396
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Associated Products
Alternative Product
Proteins & Peptides
AB201903
Recombinant Rat TNF alpha protein
proteins-peptides
recombinant-rat-tnf-alpha-protein-ab201903
0
(0 reviews)
Alternative Product
Proteins & Peptides
AB229366
Recombinant rat TNF alpha protein (Active)
proteins-peptides
recombinant-rat-tnf-alpha-protein-active-ab229366
0
(0 reviews)
Alternative Product
Proteins & Peptides
AB243118
Recombinant rhesus monkey TNF alpha protein (Active)
proteins-peptides
recombinant-rhesus-monkey-tnf-alpha-protein-active-ab243118
0
(0 reviews)
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com